Kinnate Biopharma Inc.

STATE STREET CORP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

61,959

Value ($000)

147

Weight

0.0%

2021 Q1 - 2023 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	147	0.0%	61,959	12/31/2023
2023 Q3	11/14/2023	87	0.0%	61,959	9/30/2023
2023 Q2	8/14/2023	188	0.0%	61,959	6/30/2023
2023 Q1	5/15/2023	2,915	0.0%	466,381	3/31/2023
2022 Q4	5/15/2023	2,825	0.0%	463,182	12/31/2022
2022 Q3	11/15/2022	5,575	0.0%	466,521	9/30/2022
2022 Q2	8/15/2022	5,703	0.0%	452,278	6/30/2022
2022 Q1	5/16/2022	4,765	0.0%	423,154	3/31/2022
2021 Q4	2/14/2022	6,892	0.0%	388,930	12/31/2021
2021 Q3	11/15/2021	7,656	0.0%	332,575	9/30/2021
2021 Q2	8/16/2021	5,520	0.0%	237,130	6/30/2021
2021 Q1	7/9/2021	5,711	0.0%	183,282	3/31/2021